KH
K Health, Inc.
SEC filingOther Technology · New York, NY
Amount raised$58.9Msold at filing
Total offering$68.9M$10M still open
Investors in the raise19count reported to the SEC
FiledAug 19, 2026first sale Jun 5, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ran ShaulExecutive Officer
Adam SingoldaDirector
Yaron SavorayExecutive Officer
Niyum GandhiDirector
Chen YehudaiExecutive Officer
Mark TluszczDirector
Vivek PattipatiDirector
C. Okey AgbaDirector
Nir ZoharDirector
Vivian RiefbergDirector
Zac SiegelExecutive Officer
Saad EhtishamDirector
Executive officers, directors and promoters as listed on the Form D.